Medical News

RSS

GOP playbook highlights Senate procedural tactics

A memo circulated by Sen. Judd Gregg, R-N.H., spells out the arsenal of parliamentary maneuvers available to Republicans as they seek to stall the Senate's health debate, The New York Times reports on its Prescriptions blog. Gregg has a reputation as one of the GOP's "foremost experts on legislative war games."

3 Dec 2009

iCo Therapeutics to present an overview of its iCo-007 VEGF "+" agent at the ISOPT conference

iCo Therapeutics Inc. is pleased to announce that an overview of iCo-007, entitled "iCo-007 a VEGF "+" Agent for the Potential Treatment of Diabetic Macular Edema and Diabetic Retinopathy" will be presented at the 8th International Symposium on Ocular Pharmacology and Therapeutics ("ISOPT"), a major international ocular conference.

3 Dec 2009

Doctors' groups break ranks to oppose Senate health overhaul

The California Medical Association - which represents more than 35,000 doctors - will announce its opposition to the Senate version of the health overhaul bill later this week, the Los Angeles Times reports. The group's leaders voted to oppose the bill last week, joining several other states, including Florida and Texas.

3 Dec 2009

At House hearing, panel seeks to clarify advice on mammograms

Members of the U.S. Preventive Services Task Force testified at a hearing Wednesday before the the House Energy and Commerce subcommittee on health.

3 Dec 2009

Initial positive data from Amira Pharmaceuticals' Phase 1 clinical study of AM461 DP2 antagonist

Amira Pharmaceuticals, Inc. announced today initial positive data from a Phase 1 clinical study of AM461, the Company's second oral selective antagonist of the DP2 (also known as CRTH2) receptor.

3 Dec 2009

Reid still seeks common ground on public option

"The public option has gone through several stages of evolution this year, but it could soon face extinction unless one of the new versions picks up political momentum," The Hill reports.

3 Dec 2009

States weigh health cuts; Mass. considers student health 'revision'

News outlets report on budget squeezes in Oklahoma and Florida and a proposed overhaul of student health insurance in Massachusetts.

3 Dec 2009

Fear of swine flu impacts lifestyle

One of the lasting legacies of 2009 and looming challenges of 2010 is the H1N1 virus. Fears about contracting H1N1 (commonly known as the swine flu) have consumed many Americans for most of the year, so EarnMyDegree.com (http://www.earnmydegree.com), a web resource of EducationDynamics, which connects prospective students with online classes, commissioned a new study about whether flu-related worries have caused people to change their habits.

3 Dec 2009

Enzon Pharmaceuticals announces share repurchase program

Enzon Pharmaceuticals, Inc. announced today that its Board of Directors has authorized the repurchase of up to $50 million of its outstanding shares of common stock in order to return value to its shareholders.

3 Dec 2009

Don't stop dieting during the holiday season

As Americans gear up for the holiday season this month, Dr. Sasson Moulavi, a Board Certified Bariatric Physician, cautions that overweight and obese patients not give in to temptation and forget their dieting. Rather, Dr. Sass, founder of the Smart for Life(R) Cookie Diet, recommends alternative behavior for a positive outcome when it is time to ring in the New Year.

3 Dec 2009

NIMS’ Exer-Rest acceleration therapeutic platform granted Canadian Patent

Non-Invasive Monitoring Systems, Inc. announced that the Canadian Patent Office issued Patent number 2,534,302 to NIMS on October 20, 2009. The patent, entitled “Reciprocating Movement Platform for the External Addition of Pulses to the Fluid Channels of a Subject”, relates to the comprehensively researched technology underlying NIMS’ Exer-Rest acceleration therapeutic platform.

3 Dec 2009

Spectranetics receives FDA clearance for its new VisiSheath Dilator Sheath device

Spectranetics Corporation today announced it has received Food and Drug Administration (FDA) 510(k) clearance for its new VisiSheathTM Dilator Sheath device. This expands the market for VisiSheath, which recently also received CE Mark approval in Europe.

3 Dec 2009

GTSI named value-added reseller of the Intel Health Guide RPM solution

GTSI Corp. an enterprise technology solutions and services provider was recently named a value-added reseller to deliver the Intel® Health Guide, a comprehensive, next-generation remote patient monitoring (RPM) solution that combines an in-home patient device, the Intel Health Guide PHS6000, with the Intel® Care Management Suite, an online interface that allows clinicians to monitor patients and remotely manage care.

3 Dec 2009

Milestone Scientific announces new joint venture with two PRC pharmaceutical companies

Milestone Scientific Inc., the recognized leader in advanced injection technologies, today announced that it had entered into a joint venture with China National Medicines Corporation Ltd. (d/b/a "Sinopharm") and Yichang Humanwell Pharmaceutical Co. Ltd., both incorporated in the People's Republic of China (the "PRC"), to develop orthopedic and epidural drug delivery instruments.

3 Dec 2009

Endo Pharmaceuticals receives FDA complete response letter for AVEED NDA

Endo Pharmaceuticals today announced that it received a complete response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for its extended-duration testosterone undecanoate injection, AVEED(TM), for men diagnosed with low testosterone.

3 Dec 2009

Avisio forms new subsidiary to market its virus detecting nano sensory technology

Avisio, Inc. announced today that it has formed a majority-owned subsidiary to market and commercialize Instant Detect, the company's new nano sensory technology that instantly detects biological viruses. The new company, Diagnostic Nano Applications (DNA), will be headquartered in Riverside, California.

3 Dec 2009

IsoRay to distribute Oncura's I-125 brachytherapy seed

IsoRay, Inc. announced today that it has signed a distribution agreement with Oncura to distribute the I-125 brachytherapy seed, OncoSeed™.

3 Dec 2009

New health IT grants to be 'models' for the nation

The federal government will offer $235 million in grants for communities to upgrade and improve their health information technology, The Dallas Morning News reports. Only organizations that are already using health IT are eligible. Health secretary Kathleen Sebelius said, "Our hope is that the communities will become models for the rest of the country" (Roberson, 12/2).

3 Dec 2009

FDA approves manufacture of Amneal Pharmaceuticals' Nizatidine Oral Solution

Amneal Pharmaceuticals is pleased to announce that it has received U.S. FDA approval to manufacture Nizatidine Oral Solution in the 15 mg/mL strength effective November 18, 2009. It is an AA-rated, therapeutically equivalent alternative to Axid® Oral Solution (a licensed trademark of Braintree Labs). Nizatidine Oral Solution is the first available generic in oral solution form and marks Amneal’s fourth liquid approval.

3 Dec 2009

CBO report shows hundreds of millions spent on direct marketing of drugs to consumers

The Congressional Budget Office released an "interesting report" on on how "pharmaceutical companies market prescription drugs, a subject that has received some scrutiny during the debate on ways to control health care spending," The New York Times reports.

3 Dec 2009